ES2942329T3 - Régimen de dosificación de vaborbactam y meropenem para el tratamiento de infecciones bacterianas en sujetos con función renal reducida - Google Patents
Régimen de dosificación de vaborbactam y meropenem para el tratamiento de infecciones bacterianas en sujetos con función renal reducida Download PDFInfo
- Publication number
- ES2942329T3 ES2942329T3 ES16783764T ES16783764T ES2942329T3 ES 2942329 T3 ES2942329 T3 ES 2942329T3 ES 16783764 T ES16783764 T ES 16783764T ES 16783764 T ES16783764 T ES 16783764T ES 2942329 T3 ES2942329 T3 ES 2942329T3
- Authority
- ES
- Spain
- Prior art keywords
- meropenem
- compound
- pharmaceutically acceptable
- acceptable salt
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/69—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562152668P | 2015-04-24 | 2015-04-24 | |
| PCT/US2016/028437 WO2016172208A1 (en) | 2015-04-24 | 2016-04-20 | Methods of treating bacterial infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2942329T3 true ES2942329T3 (es) | 2023-05-31 |
Family
ID=57144340
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES16783764T Active ES2942329T3 (es) | 2015-04-24 | 2016-04-20 | Régimen de dosificación de vaborbactam y meropenem para el tratamiento de infecciones bacterianas en sujetos con función renal reducida |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20160339045A1 (https=) |
| EP (1) | EP3285776B1 (https=) |
| JP (2) | JP6945452B2 (https=) |
| CN (2) | CN112755039A (https=) |
| AU (1) | AU2016252555A1 (https=) |
| CA (1) | CA2982911C (https=) |
| ES (1) | ES2942329T3 (https=) |
| WO (1) | WO2016172208A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS60310B1 (sr) | 2010-08-10 | 2020-07-31 | Rempex Pharmaceuticals Inc | Ciklični derivati estra boronske kiseline, postupak za pripremu injihove terapeutske upotrebe |
| KR20150103269A (ko) | 2013-01-04 | 2015-09-09 | 렘펙스 파머수티클스 인코퍼레이티드 | 보론산 유도체 및 그의 치료적 용도 |
| EP3139930B1 (en) | 2014-05-05 | 2024-08-14 | Melinta Therapeutics, Inc. | Salts and polymorphs of cyclic boronic acid ester derivatives and therapeutic uses thereof |
| SI3140310T1 (sl) | 2014-05-05 | 2020-01-31 | Rempex Pharmaceuticals, Inc. | Sinteza boronatnih soli in njihova uporaba |
| WO2015179308A1 (en) | 2014-05-19 | 2015-11-26 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
| EA201692301A1 (ru) | 2014-07-01 | 2017-06-30 | Ремпекс Фармасьютикалз, Инк. | Производные бороновой кислоты и их терапевтическое применение |
| WO2016081297A1 (en) | 2014-11-18 | 2016-05-26 | Rempex Pharmaceuticals, Inc. | Cyclic boronic acid ester derivatives and therapeutic uses thereof |
| US20180051041A1 (en) | 2015-03-17 | 2018-02-22 | Rempex Pharmaceuticals, Inc. | Boronic acid derivatives and therapeutic uses thereof |
| ES2894251T3 (es) | 2016-06-30 | 2022-02-14 | Qpex Biopharma Inc | Derivados de ácido borónico y usos terapéuticos de los mismos |
| MX390529B (es) * | 2017-01-09 | 2025-03-20 | Rempex Pharmaceuticals Inc | Metodos para tratar infecciones bacterianas |
| BR112020006658A2 (pt) * | 2017-10-03 | 2020-09-24 | Melinta Therapeutics, Inc. | métodos de tratamento de infecções bacterianas |
| MX2020003495A (es) | 2017-10-11 | 2020-09-18 | Qpex Biopharma Inc | Derivados de acido boronico y sintesis de los mismos. |
| US12016868B2 (en) | 2018-04-20 | 2024-06-25 | Qpex Biopharma, Inc. | Boronic acid derivatives and therapeutic uses thereof |
| BR112022022367A2 (pt) | 2020-05-05 | 2023-01-10 | Qpex Biopharma Inc | Derivados e síntese de ácido borônico, formas polimórficas e usos terapêuticos dos mesmos |
| CN116098993B (zh) * | 2022-11-17 | 2024-10-25 | 中国农业科学院特产研究所 | 一种狐、貉肺炎三联灭活疫苗及其制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4783443A (en) | 1986-03-03 | 1988-11-08 | The University Of Chicago | Amino acyl cephalosporin derivatives |
| RS60310B1 (sr) | 2010-08-10 | 2020-07-31 | Rempex Pharmaceuticals Inc | Ciklični derivati estra boronske kiseline, postupak za pripremu injihove terapeutske upotrebe |
| US10561675B2 (en) | 2012-06-06 | 2020-02-18 | Rempex Pharmaceuticals, Inc. | Cyclic boronic acid ester derivatives and therapeutic uses thereof |
-
2016
- 2016-04-20 ES ES16783764T patent/ES2942329T3/es active Active
- 2016-04-20 AU AU2016252555A patent/AU2016252555A1/en not_active Abandoned
- 2016-04-20 WO PCT/US2016/028437 patent/WO2016172208A1/en not_active Ceased
- 2016-04-20 US US15/134,198 patent/US20160339045A1/en not_active Abandoned
- 2016-04-20 CN CN202110100198.0A patent/CN112755039A/zh active Pending
- 2016-04-20 CN CN201680023884.XA patent/CN107530364A/zh active Pending
- 2016-04-20 EP EP16783764.0A patent/EP3285776B1/en active Active
- 2016-04-20 CA CA2982911A patent/CA2982911C/en active Active
- 2016-04-20 JP JP2017555494A patent/JP6945452B2/ja active Active
-
2018
- 2018-07-06 US US16/029,388 patent/US20190105337A1/en not_active Abandoned
-
2021
- 2021-06-18 JP JP2021101472A patent/JP7245289B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN107530364A (zh) | 2018-01-02 |
| AU2016252555A1 (en) | 2017-11-09 |
| JP7245289B2 (ja) | 2023-03-23 |
| EP3285776A4 (en) | 2019-01-23 |
| CN112755039A (zh) | 2021-05-07 |
| US20190105337A1 (en) | 2019-04-11 |
| US20160339045A1 (en) | 2016-11-24 |
| JP6945452B2 (ja) | 2021-10-06 |
| CA2982911A1 (en) | 2016-10-27 |
| HK1249432A1 (en) | 2018-11-02 |
| EP3285776A1 (en) | 2018-02-28 |
| CA2982911C (en) | 2023-10-03 |
| WO2016172208A1 (en) | 2016-10-27 |
| EP3285776B1 (en) | 2022-12-21 |
| JP2021143196A (ja) | 2021-09-24 |
| JP2018513188A (ja) | 2018-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2942329T3 (es) | Régimen de dosificación de vaborbactam y meropenem para el tratamiento de infecciones bacterianas en sujetos con función renal reducida | |
| US11007206B2 (en) | Cyclic boronic acid ester derivatives and therapeutic uses thereof | |
| ES2985626T3 (es) | Sales y polimorfos de derivados cíclicos de éster de ácido borónico y usos terapéuticos de los mismos | |
| ES3026983T3 (en) | Ceftolozane antibiotic compositions | |
| EP3849562B1 (en) | Combination compositions comprising a beta-lactamase inhibitor | |
| ES3036963T3 (en) | Boronic acid derivatives and therapeutic uses thereof | |
| ES2979266T3 (es) | Procedimientos de tratamiento de infecciones bacterianas con una combinación de vaborbactam y meropenem | |
| BRPI0612447A2 (pt) | composição antibiótica de dose fixa, processo para a preparação de um produto de combinação antibiótica de dose fixa, processo para a preparação de uma injeção lìquida e usos de pó seco para injeção e injeção lìquida | |
| HK40051777A (en) | Methods of treating bacterial infections | |
| HK1249432B (en) | Dosage regimen of vaborbactam and meropenem for treating bacterial infections in subjects with reduced renal function | |
| WO2014071155A1 (en) | Therapeutic uses of tigemonam and carumonam | |
| HK40097685A (en) | Methods of treating bacterial infections with vaborbactam and meropenem | |
| WO2024128238A1 (ja) | 細菌感染症の治療剤 | |
| HK40018408B (en) | Methods of treating bacterial infections with a combination of vaborbactam and meropenem | |
| HK40018408A (en) | Methods of treating bacterial infections with a combination of vaborbactam and meropenem |